Technology News and Research

RSS

Researchers discover bitter taste inhibitor

Researchers have discovered a chemical that specifically blocks people's ability to detect the bitter aftertaste that comes with artificial sweeteners such as saccharin. The key is a molecule known only as GIV3727 that specifically targets and inhibits a handful of human bitter taste receptors, according to a report published online on May 27th in Current Biology, a Cell Press publication.

28 May 2010

PuriCore sales decreases 9.9% to $10.0 million for first-quarter 2010

PuriCore, the water-based clean technology company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, today issued its Interim Management Statement covering the period January 1, 2010, to March 31, 2010.

28 May 2010

PuriCore revenue increases 28% to $40.0 million for year ending December 31, 2009

PuriCore, the water-based clean technology company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, today announced its Final Results for the year ending December 31, 2009, and the availability of its 2009 annual report on its website.

28 May 2010

Amorfix, Aragen Bioscience collaborate to develop high-affinity monoclonal antibodies against targets for cancer

Amorfix Life Sciences and Aragen Bioscience, Inc. announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Using its proprietary ProMIS(TM) computational platform discovery technology, Amorfix has identified several disease specific epitopes ("DSEs") on misfolded Fas receptor. Aragen will use those DSEs to generate highly specific monoclonal antibodies ("mAbs").

28 May 2010

Overweight, obesity and low weight affect teenagers' physical fitness

This research was developed by Dr. Enrique Garcia Artero, from the Department of Physiology of the University of Granada, and coordinated by Professor Manuel J. Castillo Garzón. To carry out this project, the researcher used data from the national and European projects AVENA (Food and Assessment of Nutritional Status of Spanish Adolescents) and HELENA (Healthy Lifestyle in Europe by Nutrition in Adolescence) and ALPHA (Assessing Levels of Physical Activity and Fitness; Public Health Executive Agency).

28 May 2010

Stanford Hospital & Clinics uses endovascular laser technology to retrieve permanently embedded IVC filters

Over the years, Susan Karnstedt had gotten used to the intermittent pain in her abdomen, chalking it up to her diet, or perhaps to her physically active lifestyle, as a water skier and yoga enthusiast.

28 May 2010

Senate to consider new bill to include technology-based learning materials for students with special needs

The state Senate will be considering a bill that would make it possible for nonpublic schools to include technology-based learning materials in the curriculum for students with special needs. The bill recently passed the state Assembly (76-0) with unanimous bipartisan support.

28 May 2010

Usage of assistive devices boosts orthopedic brace and supports market

Frost & Sullivan recently completed a study for the U.S. orthopedic braces and supports markets that provides an in-depth analysis of a range of orthopedic braces and supports, along with a comprehensive study of crucial market drivers, challenges and technology trends impacting U.S. braces and supports manufacturers today.

28 May 2010

Roche launches GS Junior System benchtop DNA sequencing platform for life science research

Roche, announced today the global launch of the GS Junior System, the company's new benchtop next-generation DNA sequencing platform for life science research. The GS Junior System, developed by 454 Life Sciences, a Roche company, provides an integrated sequencing and bioinformatics solution, all in a size that is no bigger than a typical desktop laser printer.

From Roche Sequencing and Life Science 28 May 2010

IMRT leads to fewer cases of xerostomia than other types of radiation: AHRQ report

An advanced type of cancer radiation is more successful than traditional radiation in avoiding "dry mouth" when treating head and neck cancers, but it is unknown whether the treatment is better or worse at reducing the size of tumors, according to a new comparative effectiveness review funded by HHS' Agency for Healthcare Research and Quality.

28 May 2010

AbleNet to showcase assistive technology products at Heartland Home for Independent Living

AbleNet, Inc. is showcasing its newest and most popular access, environmental controls and communications products at the Heartland Home for Independent Living. The model home is being constructed as an all-accessible home to give conference attendees first-hand experience with the many innovative design features and the leading accessibility products that enhance independent and functional living for people with disabilities.

28 May 2010

FDA grants Premarket Approval for Roche Diagnostics' Elecsys Antibody to hepatitis C virus assay

Roche Diagnostics announced today that the U.S. Food and Drug Administration (FDA) granted Premarket Approval for its Elecsys Antibody to hepatitis C virus (anti-HCV) assay. The Elecsys Anti-HCV assay is an in-vitro diagnostic test for the qualitative detection of total antibodies to hepatitis C virus in human serum or plasma.

From Roche Sequencing and Life Science 28 May 2010

BTE awards Diabetes Care Recognition Program certificates to 118 Montefiore Medical Group physicians

Bridges to Excellence, a national program that recognizes and rewards physicians for delivering better quality care, today awarded its sought-after Diabetes Care Recognition Program certificate to the 118 physicians in Montefiore Medical Center's 20 outpatient care facilities, known as the Montefiore Medical Group, for substantially lowering blood sugar levels and "bad" cholesterol levels in thousands of adult patients with diabetes.

28 May 2010

Fenwal biomedical engineer receives prestigious Junior Investigator Award for research on photopheresis

Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that on Friday, May 29, 2010, the American Society for Apheresis will present Fenwal biomedical engineer Katherine Radwanski with the prestigious Junior Investigator Award for her research on photopheresis.

28 May 2010

Smartfish announces second distribution partnership with Mobility Lab for ErgoMotion technology

Today from Medpi 2010, Smartfish Technologies announced its second strategic partnership to distribute and sell its ErgoMotion™ technology with Mobility Lab of France. As part of its agreement with Mobility Lab, Smartfish will provide its award-winning ErgoMotion technology to Mobility Lab for distribution to retailers in France, Switzerland, Netherlands, Belgium, Luxemburg and Spain. Smartfish will manufacture the resulting Mobility Lab branded products powered by ErgoMotion.

28 May 2010

Restricting salt intake helps control blood pressure in dialysis patients: Research

For kidney patients trying to control their blood pressure, reducing fluid build-up in the blood is more effective than using antihypertensive medications, according to an analysis appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

28 May 2010

Orthopedic surgeons plan to reduce usage of metal-on-metal hip implants: Survey

Millennium Research Group (MRG), the global authority on medical technology market intelligence, finds that 25% of the 150 orthopedic surgeons surveyed in its newest Physician Forum publication plan to reduce their usage of metal-on-metal hip implants over the next twelve months.

28 May 2010

Regulus Therapeutics obtains rights to intellectual property covering methods for modulating microRNA-21

Regulus Therapeutics Inc. announced today that it has obtained exclusive rights from the University of Wuerzburg to intellectual property covering methods for modulating microRNA-21. Regulus scientists and collaborators have shown that microRNA-21, (miR-21), is dysregulated in mouse models of cardiac disease and fibrosis, and that antagonizing miR-21 with therapeutic oligonucleotides targeting miR-21 inhibits fibrosis and attenuates cardiac function in such models. Regulus is currently developing a microRNA therapeutic targeting miR-21 as an anti-fibrotic therapy.

28 May 2010

InNexus Biotechnology announces research Collaboration Agreement with National Cancer Institute

InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to research proprietary technologies developed by InNexus.

28 May 2010

OHSU partners with UO, Harvard to expedite research into compounds that may prevent Fanconi anemia

Oregon Health & Science University is partnering with the University of Oregon and Harvard Medical School to expedite basic science research into new and existing drugs and compounds that may prevent the complications associated with Fanconi anemia, an inherited condition that can lead to bone marrow failure and cancer.

28 May 2010

Technology News and Research

Researchers discover bitter taste inhibitor

PuriCore sales decreases 9.9% to $10.0 million for first-quarter 2010

PuriCore revenue increases 28% to $40.0 million for year ending December 31, 2009

Amorfix, Aragen Bioscience collaborate to develop high-affinity monoclonal antibodies against targets for cancer

Overweight, obesity and low weight affect teenagers' physical fitness

Stanford Hospital & Clinics uses endovascular laser technology to retrieve permanently embedded IVC filters

Senate to consider new bill to include technology-based learning materials for students with special needs

Usage of assistive devices boosts orthopedic brace and supports market

Roche launches GS Junior System benchtop DNA sequencing platform for life science research

IMRT leads to fewer cases of xerostomia than other types of radiation: AHRQ report

AbleNet to showcase assistive technology products at Heartland Home for Independent Living

FDA grants Premarket Approval for Roche Diagnostics' Elecsys Antibody to hepatitis C virus assay

BTE awards Diabetes Care Recognition Program certificates to 118 Montefiore Medical Group physicians

Fenwal biomedical engineer receives prestigious Junior Investigator Award for research on photopheresis

Smartfish announces second distribution partnership with Mobility Lab for ErgoMotion technology

Restricting salt intake helps control blood pressure in dialysis patients: Research

Orthopedic surgeons plan to reduce usage of metal-on-metal hip implants: Survey

Regulus Therapeutics obtains rights to intellectual property covering methods for modulating microRNA-21

InNexus Biotechnology announces research Collaboration Agreement with National Cancer Institute

OHSU partners with UO, Harvard to expedite research into compounds that may prevent Fanconi anemia

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News